Novartis India plans therapy-focused acquisition and Tier 2-3 expansion

Novartis India plans therapy-aligned acquisition and Tier 2-3 market expansion. The move aims to strengthen its specialty care portfolio and deepen regional presence. Strategic acquisition could exceed ₹500 crore, boosting long-term growth. Expansion targets higher patient reach in underserved markets.

📊 STOCKS: $NOVARTIS | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Acquisition